Regulatory profile
From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.
| Rosters | Regulatory AUM | Main clients |
|---|---|---|
| Apr 2026 to Nov 2026 | — | — |
| Apr 2025 to Mar 2026 | — | — |
| Apr 2024 to Mar 2025 | — | — |
| Jun 2023 to Mar 2024 | — | — |
| May 2023 | $0 | — |
| Dec 2019 to Apr 2023 | — | — |
Schedule 13D/13G stakes
Stakes of 5% or more disclosed on Schedule 13D or 13G, each on the filer's latest filing for the security. These are event-dated stakes, not the quarter-end 13F portfolio below.
| Company | Schedule | Event date | Filed | Shares | % of class | Status |
|---|---|---|---|---|---|---|
| NCMI National CineMedia, Inc. | 13G/A | Aug 31, 2026 | 58d | 11,108,183 | 11.8% | Current |
| BUR Burford Capital Ltd | 13G/A | Jun 30, 2026 | 3mo | 20,244,986 | 9.2% | Current |
| CRSP CRISPR Therapeutics AG | 13G/A | Jun 30, 2026 | 3mo | 5,433,344 | 5.6% | Current |
| DAO Youdao, Inc. | 13G/A | Jun 30, 2026 | 3mo | 6,563,497 | 20.1% | Current |
| FLT now CPAY Corpay, Inc. | 13G/A | Jun 30, 2026 | 3mo | 5,053,072 | 7.7% | Current |
| FSV FirstService Corp | 13G/A | Jun 30, 2026 | 3mo | 3,351,419 | 7.3% | Current |
| IMAX Imax Corp | 13G/A | Jun 30, 2026 | 3mo | 5,129,735 | 9.3% | Current |
| MCS Marcus Corp | 13G/A | Jun 30, 2026 | 3mo | 2,164,636 | 9.1% | Current |
| PRAX Praxis Precision Medicines, Inc. | 13G/A | Jun 30, 2026 | 3mo | 1,526,680 | 5.5% | Current |
| PTLO Portillo's Inc. | 13G/A | Jun 30, 2026 | 3mo | 4,115,801 | 5.7% | Current |
| QXO QXO, Inc. | 13G/A | Jun 30, 2026 | 3mo | 74,084,587 | 10.2% | Current |
| RHI Robert Half Inc. | 13G/A | Jun 30, 2026 | 3mo | 9,877,840 | 9.7% | Current |
| TBBB Bbb Foods Inc | 13G/A | Jun 30, 2026 | 3mo | 6,718,920 | 8.6% | Current |
| WSE Wise Group plc | 13G | Jun 30, 2026 | 3mo | 56,530,693 | 5.5% | Current |
| BRKR Bruker Corp | 13G/A | Mar 31, 2026 | 6mo | 16,852,868 | 11.1% | Current |
| RXO RXO, Inc. | 13G/A | Mar 31, 2026 | 6mo | 34,686,304 | 21.1% | Current |
| CNK Cinemark Holdings, Inc. | 13G/A | Dec 31, 2025 | 9mo | 14,992,663 | 13% | Current |
| GXO GXO Logistics, Inc. | 13G/A | Dec 31, 2025 | 9mo | 12,961,835 | 11.3% | Current |
| ASAIY Sendas Distributor S.A. | 13G/A | Dec 31, 2024 | 1y | 156,625,672 | 11.6% | Current |
| AA Alcoa Corp | 13G | Sep 30, 2024 | 1y | 15,993,205 | 6.2% | Unconfirmed since Sep 30, 2024 |
A 13D or 13G stays in force until its filer amends it and no amendment is due without a material change, so a stake with no filing in 24 months reads unconfirmed, never sold. An amendment reporting under 5% ends the filer's duty to amend, not necessarily the holding. Shares are restated onto today's split basis. Show 11 exited, below-5% or retired stakes
Portfolio style
Not measured yet. Quarters are measured from the first covered 13F quarter, once each filing window closes.
How the bands are measured
Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestNo Portfolio Data
No 13F holdings on record; this filer discloses its stakes on Schedule 13D/13G above.